Evidence map›Paper›PMID 39613820›Full record

ArticleScientific reports2024

Cellulose functionalized magnetic beads for high throughput glycosylation analysis in biotherapeutic modalities.

Corrine Wan, Shi Jie Tay, Beiying Qiu, Sean Chia, Ian Walsh

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Corrine WanBioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01 Centros, Singapore, 138668, Republic of Singapore.
Shi Jie TayBioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01 Centros, Singapore, 138668, Republic of Singapore.
Beiying QiuBioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01 Centros, Singapore, 138668, Republic of Singapore.
Sean ChiaBioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01 Centros, Singapore, 138668, Republic of Singapore.
Ian WalshBioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01 Centros, Singapore, 138668, Republic of Singapore. ian_walsh@bti.a-star.edu.sg.

Funding

Agency for Science, Technology and Research C210112057
6 · The paper itself

Abstract

The increasing demand for biotherapeutics has necessitated the evaluation of their critical quality attributes, one of which is glycosylation, an essential post-translational modification found on many biological molecules. In particular, the purification of N-glycans after their release from the proteins and derivatization is important in ensuring the removal of the deglycosylated protein, excess labelling reagents and salts for subsequent analysis. However, current methods of N-glycans purification are either expensive, laborious, time-consuming or not catered for high throughput analysis. To overcome these constraints, we developed a high throughput purification method for fluorescent derivatized N-glycans using cellulose functionalized magnetic beads (CMBs). We compared the method with two current purification methods, hydrophilic interaction chromatography solid phase extraction (HILIC-SPE) and gel filtration using human serum IgG (hsIgG) and bovine fetuin and assessed their reproducibility. The CMB method yielded highly similar glycan profiles to the two methods with very good precision. We then assessed the compatibility of the method to purify N-glycans derivatized with different fluorescent labels (RapiFluor MS, 2-aminobenzamide and procainamide). We also applied the methodology to analyse N-glycans in the biotherapeutic protein, recombinant alpha-1-antitrypsin (rAAT) which was modified with higher sialylation content. Importantly, the method successfully captured the differences in the glycan profiles between the modified and unmodified rAAT. Finally, we automated the method together with the digestion and labelling protocol onto a robotic liquid handler for high throughput glycosylation analysis. The versatility of the CMB method, together with its affordability and robustness, may provide an alternative workflow for the high throughput analysis of glycans in biotherapeutic modalities.

Indexed as

CelluloseImmunoglobulin GPolysaccharidesalpha 1-AntitrypsinAnimalsBiological TherapyCattleFetuinsGlycosylationHigh-Throughput Screening AssaysHumansMagneticsReproducibility of ResultsSolid Phase Extractionalpha 1-AntitrypsinCelluloseFetuinsImmunoglobulin GPolysaccharides

Identifiers

PMID39613820
PMCPMC11607432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.